236 related articles for article (PubMed ID: 32815131)
61. Propeptide-mediated inhibition of cognate gingipain proteinases.
Huq NL; Seers CA; Toh EC; Dashper SG; Slakeski N; Zhang L; Ward BR; Meuric V; Chen D; Cross KJ; Reynolds EC
PLoS One; 2013; 8(6):e65447. PubMed ID: 23762374
[TBL] [Abstract][Full Text] [Related]
62. Deletion of lipoprotein PG0717 in Porphyromonas gingivalis W83 reduces gingipain activity and alters trafficking in and response by host cells.
Reyes L; Eiler-McManis E; Rodrigues PH; Chadda AS; Wallet SM; Bélanger M; Barrett AG; Alvarez S; Akin D; Dunn WA; Progulske-Fox A
PLoS One; 2013; 8(9):e74230. PubMed ID: 24069284
[TBL] [Abstract][Full Text] [Related]
63. Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50.
Rangarajan M; Hashim A; Aduse-Opoku J; Paramonov N; Hounsell EF; Curtis MA
Infect Immun; 2005 Aug; 73(8):4864-78. PubMed ID: 16041000
[TBL] [Abstract][Full Text] [Related]
64. Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.
Ruggiero S; Cosgarea R; Potempa J; Potempa B; Eick S; Chiquet M
Biochim Biophys Acta; 2013 Apr; 1832(4):517-26. PubMed ID: 23313574
[TBL] [Abstract][Full Text] [Related]
65. Characterization of the specificity of arginine-specific gingipains from Porphyromonas gingivalis reveals active site differences between different forms of the enzymes.
Ally N; Whisstock JC; Sieprawska-Lupa M; Potempa J; Le Bonniec BF; Travis J; Pike RN
Biochemistry; 2003 Oct; 42(40):11693-700. PubMed ID: 14529279
[TBL] [Abstract][Full Text] [Related]
66. Purification and characterization of gingipains.
Potempa J; Nguyen KA
Curr Protoc Protein Sci; 2007 Aug; Chapter 21():21.20.1-21.20.27. PubMed ID: 18429320
[TBL] [Abstract][Full Text] [Related]
67. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain.
Potempa J; Pike R; Travis J
Infect Immun; 1995 Apr; 63(4):1176-82. PubMed ID: 7890369
[TBL] [Abstract][Full Text] [Related]
68. Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.
Palm E; Khalaf H; Bengtsson T
Mol Oral Microbiol; 2015 Feb; 30(1):74-85. PubMed ID: 25055828
[TBL] [Abstract][Full Text] [Related]
69. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors.
Kadowaki T; Baba A; Abe N; Takii R; Hashimoto M; Tsukuba T; Okazaki S; Suda Y; Asao T; Yamamoto K
Mol Pharmacol; 2004 Dec; 66(6):1599-606. PubMed ID: 15361547
[TBL] [Abstract][Full Text] [Related]
70. Methods for Functional Characterization of the Type IX Secretion System of Porphyromonas gingivalis.
Sato K
Methods Mol Biol; 2021; 2210():123-133. PubMed ID: 32815133
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of gingipains and Porphyromonas gingivalis growth and biofilm formation by prenyl flavonoids.
Kariu T; Nakao R; Ikeda T; Nakashima K; Potempa J; Imamura T
J Periodontal Res; 2017 Feb; 52(1):89-96. PubMed ID: 26957413
[TBL] [Abstract][Full Text] [Related]
72. Porphyromonas gingivalis Gingipains Display Transpeptidation Activity.
Zhang L; Veith PD; Huq NL; Chen YY; Seers CA; Cross KJ; Gorasia DG; Reynolds EC
J Proteome Res; 2018 Aug; 17(8):2803-2818. PubMed ID: 29984580
[TBL] [Abstract][Full Text] [Related]
73. A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.
Takii R; Kadowaki T; Baba A; Tsukuba T; Yamamoto K
Infect Immun; 2005 Feb; 73(2):883-93. PubMed ID: 15664930
[TBL] [Abstract][Full Text] [Related]
74. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins.
Nonaka S; Kadowaki T; Nakanishi H
Neurochem Int; 2022 Mar; 154():105282. PubMed ID: 35032577
[TBL] [Abstract][Full Text] [Related]
75. Proteolytic processing and activation of gingipain zymogens secreted by T9SS of Porphyromonas gingivalis.
Veillard F; Sztukowska M; Nowakowska Z; Mizgalska D; Thøgersen IB; Enghild JJ; Bogyo M; Potempa B; Nguyen KA; Potempa J
Biochimie; 2019 Nov; 166():161-172. PubMed ID: 31212040
[TBL] [Abstract][Full Text] [Related]
76. Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
Gibson FC; Savelli J; Van Dyke TE; Genco CA
J Periodontol; 2005 Oct; 76(10):1629-36. PubMed ID: 16253083
[TBL] [Abstract][Full Text] [Related]
77. Porphyromonas gingivalis gingipains potentially affect MUC5AC gene expression and protein levels in respiratory epithelial cells.
Miya C; Cueno ME; Suzuki R; Maruoka S; Gon Y; Kaneko T; Yonehara Y; Imai K
FEBS Open Bio; 2021 Feb; 11(2):446-455. PubMed ID: 33332733
[TBL] [Abstract][Full Text] [Related]
78. Altered gingipain maturation in vimA- and vimE-defective isogenic mutants of Porphyromonas gingivalis.
Vanterpool E; Roy F; Sandberg L; Fletcher HM
Infect Immun; 2005 Mar; 73(3):1357-66. PubMed ID: 15731033
[TBL] [Abstract][Full Text] [Related]
79. Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis.
Mezyk-Kopec R; Bzowska M; Potempa J; Bzowska M; Jura N; Sroka A; Black RA; Bereta J
Infect Immun; 2005 Mar; 73(3):1506-14. PubMed ID: 15731048
[TBL] [Abstract][Full Text] [Related]
80. VimA is part of the maturation pathway for the major gingipains of Porphyromonas gingivalis W83.
Vanterpool E; Roy F; Zhan W; Sheets SM; Sangberg L; Fletcher HM
Microbiology (Reading); 2006 Nov; 152(Pt 11):3383-3389. PubMed ID: 17074907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
